Kudriashov, Valentin,
Sufianov, Albert,
Mashkin, Andrey,
Beilerli, Aferin,
Ilyasova, Tatiana,
Liang, Yanchao,
Lyulin, Sergey,
Beylerli, Ozal (2023) , and directing DNA synthesis.
One such class of ncRNAs that has been extensively
studied are long non-coding RNAs
Nasyrova, Regina F,
Vaiman, Elena E,
Repkina, Vera V,
Khasanova, Aiperi K,
Asadullin, Azat R,
Shipulin, German A,
Altynbekov, Kuanysh S,
Al-Zamil, Mustafa,
Petrova, Marina M,
Shnayder, Natalia A (2023) genetic
studies of the predisposition to the development of AIA. Objective: The goal of our
studyIvanova, Elizaveta,
Asadullina, Dilara,
Gilyazova, Gulshat,
Rakhimov, Radmir,
Izmailov, Adel,
Pavlov, Valentin,
Khusnutdinova, Elza,
Gilyazova, Irina (2023) . Modern
studies demonstrate the high potential of exosomal miRNAs as diagnostic
and prognostic markers
Erdman, V.V.,
Nasibullin, T.R.,
Tuktarova, I.A.,
Timasheva, Y.R.,
Danilko, K.V.,
Viktorova, T.V.,
Mustafina, O.E. (2020) For the first time, a
study of genetic factors of longevity was conducted in the prevalent
NIKITIN, A.G.,
CHUDAKOVA, D.A.,
ENIKEEV, R.F.,
GORDIEV, M.G.,
SAKAEVA, D.,
DRUZHKOV, M.,
SHIGAPOVA, L.H.,
BROVKINA, O.I.,
SHAGIMARDANOVA, E.I.,
GUSEV, O.A. (2020) (BC). In this
study, we performed Targeted Next-Generation Sequencing of MMR pathway genes MLH1, MSH2
Kazantseva, A.V.,
Davydova, Y.D.,
Enikeeva, R.F.,
Valinurov, R.G.,
Gareeva, A.E.,
Khusnutdinova, N.N.,
Khusnutdinova, E.K. (2021) manifestation. The aim of the
study: Considering a multifactorial nature of developing aggression, the present
Khidiyatova, Irina,
Khidiyatova, Indira,
Zinchenko, Rena,
Marakhonov, Andrey,
Karunas, Alexandra,
Avkhadeeva, Svetlana,
Aznzbaev, Marat,
Khusnutdinova, Elza (2023) to investigate the epidemiology of the disease, perform population
studies to determine the spectrum
Deal, C,
Steelman, J,
Vlachopapadopoulou, E,
Stawerska, R,
Silverman, LA;,
Phillip, M,
Kim, HS,
Ko, CW,
Malievskiy, O,
Cara, JF,
Roland, CL,
Taylor, CT,
Valluri, SR,
Wajnrajch, MP,
Pastrak, A,
Miller, BS (2022) .
Methods: In this 12-month, open-label, randomized, active-controlled, parallel-group, phase 3
study